Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Tadalafil and Finasteride may help treat aggressive melanoma.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Repurposing existing drugs can improve cancer treatment but faces challenges.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

Two people lost hair unexpectedly after getting a common hair loss treatment with a drug called Dutasteride.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

A new treatment using a DNA aptamer can promote hair growth by targeting a specific receptor.

Cancer treatments targeting specific cells often cause skin problems, which can affect how much medicine patients can take.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Low dose oral minoxidil helped treat long-term hair loss caused by chemotherapy in 15 patients.

Chemoprevention, using drugs like finasteride and dutasteride, can help prevent prostate cancer.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Some cancer treatments can cause abnormal fine hair growth.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.